{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:37:02Z","timestamp":1792651022968,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.heliyon.2023.e15651","type":"journal-article","created":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T20:00:14Z","timestamp":1682280014000},"page":"e15651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Method for screening influenza neutralizing antibodies in crude human plasma and its derivatives using SPR"],"prefix":"10.1016","volume":"9","author":[{"given":"Alexey M.","family":"Khalenkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata G.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4173-5014","authenticated-orcid":false,"given":"Dorothy E.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.heliyon.2023.e15651_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-2600(17)30174-1","article-title":"Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study","volume":"5","author":"Beigel","year":"2017","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15651_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15651_bib3","first-page":"489","article-title":"Successful treatment of avian influenza with convalescent plasma","volume":"12","author":"Kong","year":"2006","journal-title":"Hong Kong Med. J."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15651_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1378\/chest.12-2907","article-title":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection","volume":"144","author":"Hung","year":"2013","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e15651_bib5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-2600(19)30253-X","article-title":"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial","volume":"7","author":"Davey","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15651_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2217\/imt.11.167","article-title":"Passive immune neutralization strategies for prevention and control of influenza A infections","volume":"4","author":"Ye","year":"2012","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15651_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2002.1625","article-title":"Mechanism of neutralization of influenza virus infectivity by antibodies","volume":"302","author":"Knossow","year":"2002","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15651_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciy1003","article-title":"Immunogenicity and viral shedding of Russian-backbone, seasonal, trivalent, live, attenuated influenza vaccine in a phase II, randomized, placebo-controlled trial among preschool-aged children in urban Bangladesh","volume":"69","author":"Lewis","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e15651_bib9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15651_bib10","first-page":"223","article-title":"A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: proposals for an assay method for the haemagglutinin content of influenza vaccines","volume":"52","author":"Schild","year":"1975","journal-title":"Bull. World Health Organ."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e15651_bib11","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1128\/JVI.74.24.11825-11831.2000","article-title":"Sialic acid species as a determinant of the host range of influenza A viruses","volume":"74","author":"Suzuki","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.heliyon.2023.e15651_bib12","series-title":"Influenza Pathogenesis and Control - Volume I","first-page":"3","article-title":"The hemagglutinin: a determinant of pathogenicity","author":"B\u00f6ttcher-Friebertsh\u00e4user","year":"2014"},{"key":"10.1016\/j.heliyon.2023.e15651_bib36","series-title":"Influenza Virology: Current Topics","year":"2006"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15651_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4161\/viru.21822","article-title":"Influenza virus surveillance using surface plasmon resonance","volume":"3","author":"Suenaga","year":"2012","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15651_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.aca.2008.06.005","article-title":"Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance","volume":"623","author":"Mandenius","year":"2008","journal-title":"Anal. Chim. Acta"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15651_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1006\/viro.1996.0139","article-title":"A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor","volume":"217","author":"Takemoto","year":"1996","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e15651_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10719-007-9055-y","article-title":"Binding kinetics of influenza viruses to sialic acid-containing carbohydrates","volume":"24","author":"Hidari","year":"2007","journal-title":"Glycoconj. J."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e15651_bib17","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.bmc.2004.02.042","article-title":"Binding of an influenza A virus to a neomembrane measured by surface plasmon resonance","volume":"12","author":"Critchley","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"22","key":"10.1016\/j.heliyon.2023.e15651_bib18","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1128\/JVI.01596-12","article-title":"Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies","volume":"86","author":"Verma","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.heliyon.2023.e15651_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2010\/506363","article-title":"Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation","volume":"2010","author":"Pan","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e15651_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181999","article-title":"Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses","volume":"12","author":"Ilyushina","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15651_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196771","article-title":"Anti-neuraminidase antibodies against pandemic A\/H1N1 influenza viruses in healthy and influenza-infected individuals","volume":"13","author":"Desheva","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15651_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.virol.2009.08.014","article-title":"Changes of the receptor-binding properties of influenza B virus B\/Victoria\/504\/2000 during adaptation in chicken eggs","volume":"394","author":"Lugovtsev","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.heliyon.2023.e15651_bib23","volume":"vol. 52","author":"Kreil","year":"2012"},{"key":"10.1016\/j.heliyon.2023.e15651_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1743-422X-11-70","article-title":"Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice","volume":"11","author":"Hohenadl","year":"2014","journal-title":"Virol. J."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2023.e15651_bib26","first-page":"409","article-title":"Non-specific inhibitors of influenza viruses in normal sera","volume":"22","author":"Ananthanarayan","year":"1960","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.heliyon.2023.e15651_bib27","series-title":"Hemagglutination Inhibition Test. Advanced Laboratory Techniques for Influenza Diagnosis. Immunology Series No. 6","author":"Palmer","year":"1975"},{"issue":"16","key":"10.1016\/j.heliyon.2023.e15651_bib33","first-page":"477","article-title":"Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010","volume":"59","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e15651_bib28","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/CVI.00509-09","article-title":"Flexible label-free quantitative assay for antibodies to influenza virus hemagglutinins","volume":"17","author":"Carney","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e15651_bib29","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"5772","key":"10.1016\/j.heliyon.2023.e15651_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.1124513","article-title":"Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus","volume":"312","author":"Stevens","year":"2006","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.heliyon.2023.e15651_bib31","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.vaccine.2014.02.049","article-title":"Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency","volume":"32","author":"Khurana","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15651_bib32","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/trf.14530","article-title":"Characterization of source plasma from self-identified vaccinated or convalescent donors during the 2009 H1N1 pandemic","volume":"58","author":"Khalenkov","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.heliyon.2023.e15651_bib34","first-page":"1","article-title":"Sialic acid receptors of viruses","volume":"367","author":"Matrosovich","year":"2015","journal-title":"Top. Curr. Chem."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15651_bib35","article-title":"The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402302858X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402302858X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:58:28Z","timestamp":1773395908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402302858X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S240584402302858X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15651","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Method for screening influenza neutralizing antibodies in crude human plasma and its derivatives using SPR","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e15651"}}